English中文
  Home
eFreight
 
  Company News
  Industry News
  News Center
 
 
Air cargo prepares for biggest ever product launch as vaccine nears roll-out

〖2020-11-13〗

THE air cargo industry is preparing for what has been described as the biggest product launch in the history of mankind as a Covid-19 vaccine is set to begin distribution this year.

This follows this week's announcement that developers Pfizer and BioNTech that trials had shown that its vaccine could prevent more than 90 per cent of people from getting Covid-19.


The two firms will now apply for emergency approval to start using the vaccine before the end of November.


The developers hope to be able to supply 50 million doses by the end of this year and around 1.3 billion by the end of 2021. Each person will need to have two doses.


Importantly, the vaccine will need to be stored and transported at minus 80 degrees Celsius, which immediately limits the number of facilities that will be able to handle the vaccine.


Earlier this year, IATA calculated that 8 billion doses - to vaccinate the entire global population - would require around 8,000 B747 aircraft - and that's just under the assumption that a single dose is required.


On that basis, 50 B747 freighter flights worth of capacity will be required for doses produced this year and 1,300 by the end of 2021. However, this statistic is meant to demonstrate the amount of capacity required and in reality doses will be transported from various manufacturing sites to various markets.


Also, overland transport will come into play, taking much of the strain from air cargo, reports London's Air Cargo News.


A white paper from supply chain consultant Europhia Consulting shows that around 3.9 billion people live in a country where vaccines are likely to manufactured 'locally', while 4.2 billion people live in countries that are likely to need a vaccine to be shipped in from other parts of the world.


The biggest challenge will be connecting manufacturer production sites to distribution markets, Europhia said.


"For large distribution markets such as the US, Europe, Russia, India, China and Brazil, most vaccines will probably be distributed from 'local' production sites using road transport," the consultant explained.


"The capacity requirements of temperature-controlled trucks will be substantial. On the other hand, there will be many other countries across all continents that will require airfreight solutions to get access to vaccines. Each will face their own set of challenges including capacity constraints."


The consultant said that IATA's estimate could be an understated number.


"For example, to illustrate the massive scale of capacity required, the current population of the United Kingdom is 62 million people" it said. "Around 100 B777 freighters would be needed to transport a vaccine (double doses per capita) to immunise the UK's entire population from a faraway manufacturer. That's just to serve the needs of one country."


It added that airfreight rates should be expected to increase due to capacity constraints as a result of the grounding of bellyhold operations.


The Europhia white paper also looked at other challenges vaccine distribution will face.


Pfizer has stated that its vaccine will need storage and transport temperature of its vaccine to be as low as minus 80 degrees Celsius. Another vaccine being developed by Moderna's will need a storage and transport temperature of minus 20 degrees Celsius.


"The industry was earlier getting ready to transport these vaccines at temperatures ranging from 2 to 8 degrees. Temperature needs such as minus 20 degress Celsius and minus 80 degrees Celsius will further add to complexities since the logistics industry has never seen such kind of a challenge before," Europhia said.


"Many airports do not have such facilities to store large volumes of pharmaceutical products at 2-8 degress Celsius.


"Using actively cooled containers such as Envirotainers, Skycells and C-Safes could help mitigate some of the risks however the next challenge would be to get these vaccines safely transported to a safe cold chain storage facility in some of these emerging countries.


"Transiting the goods in emerging countries through airports and into trucks will likely form a major challenge.


"Moreover, if frozen storage is required, there are limited airports worldwide that have sufficient deep-freeze warehouse capacity available. For example, there are only four airports in the entire African continent that have this option."


There could also be challenges in delivering the product, with limited reefer truck capacity in some markets. Security will be another concern.


"Whilst a lot of countries and logistics companies have already started to build additional temperature-controlled storage facilities, there is still a long way to go," the consultant added.

 
  Contact UsJob OpportuniesSite Map
 
@ 2008 AWOT All Rights Reserved. 粵ICP備08007654號
1千炮捕鱼网站 计算器中国足球胜平负 快速赛车的技巧视频 理财产品有哪些 qq游戏长春麻将刷分 福彩快三网上投注平台 广西快3早上几点开始 体彩p5中奖新闻 七乐彩走势图 湖南幸运赛车破解版 快乐12出号规律 全民欢乐捕鱼2021_2022新上线 安徽时时彩开奖走势图一首页 15选5预测推荐杀号360 体育彩票6十1开奖查询 极速快乐十分假的 bet365真人百家乐赌博